We are live on
!
Find out more
SCM
Shelton Capital Management Portfolio holdings
AUM
$4.57B
1-Year Est. Return
32.26%
This Fund
S&P 500
This Quarter
Est. Return
+10.16%
1 Year Est. Return
+32.26%
3 Year Est. Return
+110.31%
5 Year Est. Return
+153.06%
10 Year Est. Return
+630.09%
AUM
$661M
AUM Growth
+$63.6M
(+11%)
Cap. Flow
+$8.57M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
16.59%
Holding
777
New
87
Increased
152
Reduced
160
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axos Financial
AX
|
+$1.14M |
| 2 |
Intercontinental Exchange
ICE
|
+$1.1M |
| 3 |
Exelixis
EXEL
|
+$1.1M |
| 4 |
Tesla
TSLA
|
+$1.09M |
| 5 |
Intel
INTC
|
+$582K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$3.57M |
| 2 |
FLG
Flagstar Bank National Association
FLG
|
+$1.62M |
| 3 |
CELG
Celgene Corp
CELG
|
+$1.59M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$1.54M |
| 5 |
Ametek
AME
|
+$1.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.89% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.41% |
| 4 | Industrials | 10.23% |
| 5 | Energy | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERN
276
DELISTED
Cerner Corp
CERN
| $557K | 0.08% |
9,991
+1,735
| +21% | +$97.2K |
|
|
EV
277
DELISTED
Eaton Vance Corp.
EV
| $557K | 0.08% |
13,027
| – | – |
|
278
American International
AIG
$39.8B
| $555K | 0.08% |
10,870
| – | – |
|
|
ATML
279
DELISTED
ATMEL CORP
ATML
| $554K | 0.08% |
70,803
+6,915
| +11% | +$50.6K |
|
280
Jack Henry & Associates
JKHY
$10.8B
| $553K | 0.08% |
9,333
-444
| -5% | -$24.8K |
|
281
Leidos
LDOS
$17.6B
| $551K | 0.08% |
+11,859
| New | +$547K |
|
282
Trinity Industries
TRN
$2.3B
| $551K | 0.08% |
28,069
+2,967
| +12% | +$53.8K |
|
283
DTE Energy
DTE
$28.9B
| $548K | 0.08% |
9,703
| – | – |
|
|
CVD
284
DELISTED
COVANCE INC.
CVD
| $545K | 0.08% |
6,194
| – | – |
|
285
Kohl's
KSS
$2.19B
| $544K | 0.08% |
9,587
-100
| -1% | -$5.48K |
|
|
PNRA
286
DELISTED
Panera Bread Co
PNRA
| $542K | 0.08% |
3,067
-99
| -3% | -$16.6K |
|
|
SLH
287
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
| $541K | 0.08% |
7,649
| – | – |
|
288
Global Payments
GPN
$23.4B
| $538K | 0.08% |
16,546
-1,112
| -6% | -$33.7K |
|
|
DRE
289
DELISTED
Duke Realty Corp.
DRE
| $538K | 0.08% |
35,779
| – | – |
|
|
BRCM
290
DELISTED
BROADCOM CORP CL-A
BRCM
| $536K | 0.08% |
18,075
+5,232
| +41% | +$142K |
|
291
Camden Property Trust
CPT
$10.9B
| $535K | 0.08% |
9,399
| – | – |
|
|
TUP
292
DELISTED
Tupperware Brands Corporation
TUP
| $535K | 0.08% |
5,660
-348
| -6% | -$31.6K |
|
|
MON
293
DELISTED
Monsanto Co
MON
| $535K | 0.08% |
4,590
-4,000
| -47% | -$437K |
|
294
W.R. Berkley
WRB
$25.9B
| $531K | 0.08% |
41,293
| – | – |
|
295
UGI
UGI
$7.53B
| $530K | 0.08% |
19,179
| – | – |
|
296
SEI Investments
SEIC
$12.7B
| $529K | 0.08% |
15,223
| – | – |
|
|
GWR
297
DELISTED
Genesee & Wyoming Inc.
GWR
| $528K | 0.08% |
5,497
| – | – |
|
298
East-West Bancorp
EWBC
$18.5B
| $527K | 0.08% |
15,073
-488
| -3% | -$16.6K |
|
299
Graco
GGG
$13.4B
| $527K | 0.08% |
20,229
| – | – |
|
300
Accenture
ACN
$110B
| $524K | 0.08% |
6,370
-900
| -12% | -$68.1K |
|
Similar funds
SV
LNWTC
VCM
ACM
JRP
MA
GIBU
EI
Shelton Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Shelton Capital Management held 777 positions worth $661M, up 11% from $598M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Shelton Capital Management's Q4 2013 filing shows 87 new, 152 increased, 160 reduced and 27 closed positions. Its largest new stake was Axos Financial: 63,596 shares worth $1.25M. The largest sale was BioMarin Pharmaceuticals, an estimated $3.57M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Shelton Capital Management's largest Q4 2013 buy was Axos Financial: 63,596 shares worth $1.25M.
- Shelton Capital Management added most to Tesla in Q4 2013, an estimated $1.09M increase.
- Shelton Capital Management's biggest Q4 2013 reduction was BioMarin Pharmaceuticals, cutting an estimated $3.57M.
- Shelton Capital Management fully exited Ametek in Q4 2013, selling an estimated $1.25M.
- Shelton Capital Management's ten largest holdings make up 17% of its $661M portfolio in Q4 2013.
- Shelton Capital Management opened 87 new positions and closed 27 in Q4 2013.
- Shelton Capital Management's portfolio value rose 11% quarter-over-quarter to $661M.
Based on Shelton Capital Management's 13F filing for Q4 2013, filed 22 Jan 2014.